Clinical Trials on 糖尿病神经病变 in Australia
总计763个结果
-
Ionis Pharmaceuticals, Inc.完全的
-
argenx主动,不招人多灶性运动神经病美国, 法国, 德国, 比利时, 意大利, 荷兰, 加拿大, 英国, 奥地利, 波兰, 西班牙
-
Garvan Institute of Medical ResearchWeizmann Institute of Science主动,不招人
-
Novo Nordisk A/S完全的
-
QL Biopharmaceutical Australia Pty LtdNovotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,Ltd招聘中
-
Bayside HealthBaker Heart Research Institute; International Diabetes Institute, Australia终止
-
Resverlogix CorpNucleus Network Ltd; Baker Heart and Diabetes Institute完全的
-
Aposcience AGFGK Clinical Research GmbH完全的
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); Sunnybrook Research Institute招聘中
-
Augenabteilung Allgemeines Krankenhaus Linz未知
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Mater Mothers' Hospital完全的
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.尚未招聘
-
Gold Coast Hospital and Health ServiceUniversity of Canberra完全的
-
Baker Heart Research InstituteNational Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes Australia完全的
-
University of CambridgeThe Hospital for Sick Children; Pfizer; Juvenile Diabetes Research Foundation; University of Oxford 和其他合作者完全的
-
University of Calgary招聘中
-
Unilever R&DCommonwealth Scientific and Industrial Research Organisation, Australia完全的
-
Mozart Therapeutics Australia Pty Ltd尚未招聘
-
Hunter and New England Health完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
University of AdelaideSalk Institute for Biological Studies终止
-
University of SydneyUniversity of Melbourne; The University of Western Australia; Marsden Eye Specialists完全的
-
Eli Lilly and Company终止
-
Bausch & Lomb Incorporated完全的
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.完全的